Clinical trial
NeuroRecoVR: Phase I Split-Belt Treadmill Dosing for Subacute Stroke
NCT07469163 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NeuroRecoVR: Phase I Split-Belt Treadmill Dosing for Subacute Stroke
- Lead sponsor
- University of Calgary
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 1, 2026
- Completion date
- August 31, 2026
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stroke, stroke (subacute), stroke gait rehabilitation, subacute stroke